# 7 Critical Medication Questions for Adults Over 65

Essential pharmacist consultations to manage polypharmacy risks in seniors

- **Source:** [SavingAdvice.com Blog](https://brifing.si/source/0a5be9fd-36c9-42ed-8bc4-90f6e843d3b4)
- **Published:** 2026-09-26
- **Original article:** <https://www.savingadvice.com/articles/2026/09/26/10748025_taking-several-medications-after-65-these-7-questions-are-worth-asking-your-pharmacist.html>
- **On Brifing:** https://brifing.si/s/ada1118f-9c6f-4fc2-8b07-566f11932431

## Polypharmacy risks in aging

After 65, adults typically manage multiple prescriptions alongside OTC drugs and supplements, creating complex interaction risks. The National Institute on Aging highlights how aging alters drug metabolism while multiple medications increase side effect potential. Pharmacists become crucial allies when patients bring complete medication lists, including non-prescription items often omitted from digital records.

## Hidden ingredient duplication

Many seniors unknowingly double-dose active ingredients through combination products like pain relievers and cold medicines. The NIA warns about acetaminophen overlap in different medications. Pharmacists can cross-check all products when patients bring physical labels or photos, preventing accidental overdoses that home label reading might miss due to small print or confusing terminology.

## Side effects masquerading as aging

Common symptoms like dizziness or memory issues may stem from medications rather than natural aging. The FDA advises tracking symptom onset relative to new prescriptions or dosage changes. Pharmacists help determine when to consult prescribers about adjustments, as abrupt self-discontinuation of certain drugs can cause withdrawal effects or condition flare-ups.

## Timing and administration complexities

Juggling multiple medications requires precise scheduling around meals and other drugs. FDA guidelines emphasize asking pharmacists about food interactions, optimal timing, and missed dose protocols. For seniors struggling with complex regimens, pharmacists can recommend organizational tools or suggest prescriber consultations about simplification opportunities.

## Medication necessity reviews

The NIA promotes 'deprescribing' - systematically evaluating whether older medications remain necessary. Pharmacists help identify candidates for discussion with prescribers, especially when multiple specialists prescribe separately. This differs from self-discontinuation, focusing instead on making each medication purposeful rather than arbitrarily reducing quantities.

## Cost-saving strategies

With Medicare Part D out-of-pocket caps coming in 2026, pharmacists can identify generics, alternative formulations, or different fulfillment options to reduce expenses. The FDA specifically recommends asking about lower-cost alternatives before resorting to dangerous practices like dose-skipping. Some Medicare plans offer Medication Therapy Management programs for comprehensive cost/benefit analyses.

## Comprehensive medication reviews

Medicare requires plans to offer Medication Therapy Management for qualifying beneficiaries, providing full medication assessments at no cost. Even without qualification, pharmacists can perform basic reviews to identify interaction risks or unnecessary medications. These go beyond single-prescription consultations to evaluate the entire medication ecosystem.

## Documentation as prevention

The FDA recommends maintaining current medication lists including dosages and purposes, shared with all healthcare providers. This becomes critical during emergencies or specialist visits where full medication histories might otherwise be missed. Digital or paper lists should accompany patients to every medical appointment and pharmacy visit.

## Sources covering this story

- https://www.savingadvice.com/articles/2026/09/26/10748025_taking-several-medications-after-65-these-7-questions-are-worth-asking-your-pharmacist.html — 

---

_Summary written by Brifing from the original reporting. Copyright in the original article belongs to its publisher; read the full piece at the link above._
